PHLDA3 was previously shown to function as a unique AKT inhibitor through the depletion of membrane-bound phosphatidyl inositols [28], however, the physiological function of PHLDA2 in lung cancer has not been defined. Here, PHLDA3 is linked to lung carcinoma.